Arkolith/Insider Trading/GENB/Form 4

Bancel Stephane

DirectorGenerate Biomedicines, Inc. (GENB) · full profile →Form 4 · filed Mar 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Conversion(C)724K——724K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Conversion(C)1.1M—$00
Feb 26, 2026Grant(A)30K—$030K

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-085881) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML